Cite
Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions
MLA
Matthew A. Miller, et al. “Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.” Annual Review of Pharmacology and Toxicology, vol. 59, Aug. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a3e180e9b218f94f9a8111822f547928&authtype=sso&custid=ns315887.
APA
Matthew A. Miller, Jonathan Peter, Simon Mallal, Katie D. White, Katherine C. Konvinse, Rannakoe J. Lehloenya, Alec J. Redwood, Jason H. Karnes, Rebecca Pavlos, & Elizabeth J. Phillips. (2018). Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions. Annual Review of Pharmacology and Toxicology, 59.
Chicago
Matthew A. Miller, Jonathan Peter, Simon Mallal, Katie D. White, Katherine C. Konvinse, Rannakoe J. Lehloenya, Alec J. Redwood, Jason H. Karnes, Rebecca Pavlos, and Elizabeth J. Phillips. 2018. “Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.” Annual Review of Pharmacology and Toxicology 59 (August). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....a3e180e9b218f94f9a8111822f547928&authtype=sso&custid=ns315887.